weird the backers at 60c aren't buying on market to lower average cost. That's what I would do if I was paying 6m at 60c. Market doesn't believe the deal.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential